Skip to main content
Clinical Trials/CTRI/2024/08/072578
CTRI/2024/08/072578Not yet recruitingNot Applicable

A cross sectional observation study of lipid profile in chronic liver disease patients.

Jay Bhadja1 site in 1 country72 target enrollmentStarted: August 26, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
72
Locations
1
Primary Endpoint
To assess lipid profile abnormalities in patients with chronic liver disease.

Study Overview

Brief Summary

AIMS AND OBJECTIVE:

AIM :

Feasibility of lipid profile as a prognostic marker in chronic liver disease

Primary objective:

To assess lipid profile abnormalities in patients with chronic liver disease.

Secondary objective :

To correlate that with severity of Chronic liver disease.

Use of lipid profile as an additional marker in scoring system.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
12.00 Year(s) to 75.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Patients of both genders above age of 12 2.Patients giving consent for the study.

Exclusion Criteria

  • 1.Pregnant women 2.Chronic kidney disease 3.Hematological and other malignancy 4.Recent intake of hepatotoxic and cholestatic drug.

Outcomes

Primary Outcomes

To assess lipid profile abnormalities in patients with chronic liver disease.

Time Frame: 1 year

Secondary Outcomes

  • Study outcome is yet to come(1 year)

Investigators

Sponsor
Jay Bhadja
Sponsor Class
Other [Primary investigator ]
Responsible Party
Principal Investigator
Principal Investigator

Dr Jay Bhadja

Dr DY Patil Medical College, Navi Mumbai

Study Sites (1)

Loading locations...

Similar Trials